Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
55 studies found for:    18F-FLT
Show Display Options
Rank Status Study
1 Unknown  A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma
Conditions: Brain Cancer;   Cancer;   Solid Tumor;   Lymphoma
Intervention: Biological: 18F-FLT
2 Terminated Pilot Study of 18F-FLT PET
Conditions: CNS Brain Metastasis;   Head and Neck Cancer;   Lung Cancer;   Prostate Cancer;   Esophageal Cancer
Intervention: Procedure: Imaging with 18F-FLT PET
3 Active, not recruiting 18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma
Conditions: Adult Supratentorial Primitive Neuroectodermal Tumor (PNET);   Ewing Sarcoma of Bone;   Extraosseous Ewing Sarcoma;   Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Other: fluorine F 18 fluorothymidine;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: diffusion-weighted magnetic resonance imaging;   Other: laboratory biomarker analysis
4 Unknown  18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound
Condition: Breast Neoplasms
Intervention: Drug: 18F-FLT
5 Terminated A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors
Condition: Tumors of the Central Nervous System
Intervention: Other: [18F]-Fluorothymidine
6 Recruiting An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine
Condition: Pancreatic Cancer
Intervention: Procedure: Positron-Emission Tomography (PET) 18F-FLT
7 Unknown  Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors
Condition: Lung Cancer
8 Recruiting 18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
Conditions: Metastatic Malignant Neoplasm in the Brain;   Primary Brain Neoplasm;   Recurrent Brain Neoplasm
Interventions: Procedure: Computed Tomography;   Radiation: Fluorothymidine F-18;   Procedure: Positron Emission Tomography
9 Completed
Has Results
18F-FLT-PET in Breast Cancer (MK-0000-139)
Condition: Breast Cancer
Intervention: Radiation: 18F-FLT-PET/CT Imaging
10 Active, not recruiting Image-Guided Stereotactic Biopsy of High Grade Gliomas
Conditions: Brain Cancer;   Glioma
Intervention: Drug: 18F-FLT PET Scan
11 Withdrawn 18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
Conditions: Carcinoma, Non-Small-Cell Lung;   Thymus Neoplasms
Interventions: Drug: 3'-deoxy-3'-18F fluorothymidine (FLT);   Other: PET/CT scan
12 Completed
Has Results
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer
Conditions: Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Procedure: CT;   Drug: 18F-FLT;   Procedure: PET
13 Unknown  18F-FLT Positron Emission Tomography and Magnetic Resonance Imaging of the Breast
Condition: Breast Cancer
Intervention: Drug: PET
14 Terminated Validation of 18F-MISO-PET and 18F-FLT-PET
Condition: Head and Neck Neoplasms
Intervention: Procedure: 18F-FLT and 18F-MISO-PET
15 Recruiting Dexamethasone Effects in Patients With Refractory Advanced Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Dexamethasone;   Device: Device for PET;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
16 Unknown  Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient
Conditions: Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent;   No EGFR Activating Mutation
Interventions: Radiation: 18F-FLT-TEP;   Radiation: 18F-FDG-TEP
17 Recruiting 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain
Condition: Metastatic Breast Cancer to the Brain
Intervention: Device: 18F-FLT-PET Imaging
18 Not yet recruiting 18F-FLT PET Imaging in Patients With Advanced Melanoma
Condition: Melanoma
Interventions: Drug: fludeoxyglucose F 18;   Device: Positron emission tomography-computed tomography;   Drug: 18F-fluorothymidine;   Device: Positron emission tomography-magnetic resonance imaging
19 Completed GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Conditions: Breast Cancer;   Brain Metastases
Interventions: Drug: GRN1005;   Drug: Trastuzumab;   Drug: 18F-FLT
20 Recruiting Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Conditions: Myelodysplastic Syndrome RAEB 2;   Acute Lymphocytic Leukemia;   Acute Myelogenous Leukemia;   Myelodysplastic Syndrome RAEB 1
Interventions: Procedure: Allogeneic HSC Transplantation;   Drug: Lupron;   Drug: 18F FLT;   Drug: Cyclophosphamide;   Drug: Methotrexate;   Drug: Tacrolimus;   Radiation: Total Body Irradiation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years